Department of Plastic, Reconstructive and Hand Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
Breast Cancer Res Treat. 2020 Jan;179(1):131-138. doi: 10.1007/s10549-019-05450-2. Epub 2019 Sep 21.
Breast cancer-related lymphedema (BCRL) is caused by an interruption of the lymphatic system after breast cancer treatment. Lymphaticovenous anastomosis (LVA), by which one or more patent lymphatic collecting vessels are connected to subcutaneous veins, shows promising results. Postoperatively, the patency of these anastomosis can be evaluated; however, little is known concerning the long-term patency after LVA in patients with BCRL. The aim of this study was to analyse the long-term patency, quality of life (QoL) and arm circumference after LVA, and to explore differences between patent and non-patent anastomosis and its correlation with clinical improvement.
Twenty-five patients underwent indocyanine green (ICG) lymphography, lymph ICF-questionnaire, and arm circumference measurement preoperatively and 12 months after the LVA procedure.
Seventy-six percent of the patients showed at least one patent anastomosis after 12 months. Quality of life according to the Lymph-ICF increased significantly (p < 0.000); however, arm circumference showed no significant decrease. Sixty-five percent discontinued wearing compression stockings. The patent anastomosis group, compared with the non-patent anastomosis group showed, without significance, more improvement in QoL, arm circumference, and discontinuation of compression stockings, as well as a lower rate of infections both pre- and postoperatively, a shorter duration of lymphedema preoperatively, and a higher rate of early lymphedema and ICG stage.
LVA showed an acceptable patency and positive correlation between a patent anastomosis and clinical improvement after 12 months. Further research with a larger study population is required to determine whether outcomes or patient characteristics significantly correlate with a patent anastomosis after LVA operation.
乳腺癌相关淋巴水肿(BCRL)是乳腺癌治疗后淋巴系统中断引起的。淋巴管静脉吻合术(LVA)通过将一条或多条通畅的淋巴收集管与皮下静脉连接,显示出有希望的结果。术后,可以评估这些吻合口的通畅性;然而,对于 LVA 后 BCRL 患者的长期通畅性知之甚少。本研究旨在分析 LVA 后的长期通畅性、生活质量(QoL)和臂围,并探讨通畅和非通畅吻合口之间的差异及其与临床改善的相关性。
25 例患者在 LVA 术前和术后 12 个月进行吲哚菁绿(ICG)淋巴造影、淋巴 ICF 问卷和臂围测量。
76%的患者在 12 个月后至少有一条通畅的吻合口。根据淋巴 ICF 的生活质量显著增加(p<0.000);然而,臂围没有显著减少。65%的患者停止穿压缩袜。与非通畅吻合口组相比,通畅吻合口组在 QoL、臂围和停止穿压缩袜方面的改善更为显著,且术前和术后感染率较低,术前淋巴水肿持续时间较短,早期淋巴水肿和 ICG 分期较高。
LVA 具有可接受的通畅性,并且通畅的吻合口与 12 个月后的临床改善之间存在正相关。需要进一步研究更大的研究人群,以确定结局或患者特征是否与 LVA 手术后的通畅吻合口显著相关。